{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:21:03Z","timestamp":1790367663645,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The relationship between body composition and the risk of overt hepatic encephalopathy (OHE) following transjugular intrahepatic portosystemic shunt (TIPS) needs to be investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Overall, 571 patients from 5 medical centers were included. To assess body compositions, we evaluated skeletal muscle indices, adipose tissue indices, sarcopenia, and myosteatosis at the third lumbar vertebral level. Univariate and Multivariate logistic regression analyses were performed to identify independent risk factors for post-TIPS OHE. An integrated score was then constructed using stepwise multiple regression analyses, with a cut-off value selected using the best Youden index. Finally, the Akaike information criterion (AIC) was performed to compare the integrated score and independent risk factors on their ability in predicting post-TIPS OHE.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Sarcopenia and all skeletal muscle indices had limited associations with post-TIPS OHE. The index of the subcutaneous adipose tissue (SATI) (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.005; OR: 1.034, 95% CI: 1.010\u20131.058) and myosteatosis (297 cases, 52.01%, 125 with OHE, 42.09%; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.003; OR: 1.973; 95% CI: 1.262\u20133.084) were both ascertained as independent risk factors for post-TIPS OHE. The integrated score (Score<jats:sup>ALL<\/jats:sup>=1.5760 + 0.0107 * SATI + 0.8579 * myosteatosis) was established with a cutoff value of \u22120.935. The akaike information criterion (AIC) of Score<jats:sup>ALL<\/jats:sup>, SATI, and myosteatosis was 655.28, 691.18, and 686.60, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>SATI and myosteatosis are independent risk factors for post-TIPS OHE. However, the integrated score was more significantly associated with post-TIPS OHE than other skeletal muscle and adipose tissue factors.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mcg.0000000000002014","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T15:02:17Z","timestamp":1714402937000},"page":"262-268","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Body Compositions Correlate With Overt Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt"],"prefix":"10.1097","volume":"59","author":[{"given":"Wenfeng","family":"Shi","sequence":"first","affiliation":[{"name":"Department of General Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Xu","sequence":"additional","affiliation":[{"name":"Zhuhai Interventional Medical Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Zhuhai People\u2019s Hospital (Zhuhai Clinical Medical College of Jinan University), Zhuhai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[{"name":"Zhuhai Interventional Medical Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiong","family":"Chen","sequence":"additional","affiliation":[{"name":"Zhuhai Interventional Medical Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhao","sequence":"additional","affiliation":[{"name":"Zhuhai Interventional Medical Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Bai","sequence":"additional","affiliation":[{"name":"Zhuhai Interventional Medical Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"Zhuhai Interventional Medical Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3]]},"reference":[{"key":"R1-20250310","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.28318","article-title":"Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy1b-blocker for prevention of variceal rebleeding","volume":"63","author":"Holster","year":"2016","journal-title":"Hepatology"},{"key":"R2-20250310","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/hepr.12195","article-title":"Predictive factors for improvement of ascites after transjugular intrahepatic portosystemic shunt in patients with refractory ascites","volume":"44","author":"Taki","year":"2014","journal-title":"Hepatol Res"},{"key":"R3-20250310","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol"},{"key":"R4-20250310","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American association for the study of liver diseases","volume":"65","author":"Garcia Tsao","year":"2016","journal-title":"Hepatology"},{"key":"R5-20250310","first-page":"406","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2016","journal-title":"J Hepatol"},{"key":"R6-20250310","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jhep.2019.01.017","article-title":"Hepatic encephalopathy and traffic accidents: Vigilance is needed!","volume":"70","author":"Tapper","year":"2019","journal-title":"J Hepatol"},{"key":"R7-20250310","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jvir.2018.08.023","article-title":"Early-recurrent overt hepatic encephalopathy is associated with reduced survival in cirrhotic patients after transjugular intrahepatic portosystemic shunt creation","volume":"30","author":"Zuo","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"R8-20250310","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2004.12.028","article-title":"Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: A randomized controlled study","volume":"42","author":"Riggio","year":"2005","journal-title":"J Hepatol"},{"key":"R9-20250310","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/apt.17252","article-title":"Effect of time to pre-emptive transjugular intrahepatic portosystemic shunt on patient outcome, a UK multicentre cohort study","volume":"57","author":"Dunne","year":"2023","journal-title":"Aliment Pharm Therap"},{"key":"R10-20250310","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American association for the study of liver diseases and the European association for the study of the liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"R11-20250310","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MCG.0000000000000339","article-title":"A standardized assessment of functional disability predicts 1-year mortality in patients undergoing transjugular intrahepatic portosystemic shunt for refractory ascites","volume":"50","author":"Grunwald","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"R12-20250310","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s12072-021-10188-5","article-title":"Prediction of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt treatment: A cohort study","volume":"15","author":"Yang","year":"2021","journal-title":"Hepatol Int"},{"key":"R13-20250310","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/MCG.0000000000001305","article-title":"Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for gastric varices: A meta-analysis","volume":"55","author":"Yu","year":"2021","journal-title":"J Clin Gastroenterol"},{"key":"R14-20250310","doi-asserted-by":"crossref","first-page":"9381","DOI":"10.1038\/s41598-020-65227-2","article-title":"A nomogram to predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients","volume":"10","author":"Yin","year":"2020","journal-title":"Sci Rep"},{"key":"R15-20250310","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/hep.30692","article-title":"Muscle alterations are associated with minimal and overt hepatic encephalopathy in patients with liver cirrhosis","volume":"70","author":"Nardelli","year":"2019","journal-title":"Hepatology"},{"key":"R16-20250310","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s13244-015-0414-0","article-title":"Imaging body composition in cancer patients: Visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome","volume":"6","author":"Yip","year":"2015","journal-title":"Insights Imaging"},{"key":"R17-20250310","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13244-021-01106-2","article-title":"Diagnosing sarcopenia and myosteatosis based on chest computed tomography images in healthy Chinese adults","volume":"12","author":"Tan","year":"2021","journal-title":"Insights Imaging"},{"key":"R18-20250310","first-page":"94","article-title":"Adipopenia is the rapid screening tool that best predicts mortality in patients with decompensated cirrhosis: Results of a prospective study","volume":"30","author":"De Luca","year":"2021","journal-title":"J Gastrointestin Liver Dis"},{"key":"R19-20250310","doi-asserted-by":"crossref","first-page":"h4187","DOI":"10.1136\/bmj.h4187","article-title":"Hepatic encephalopathy due to liver cirrhosis","volume":"351","author":"Ellul","year":"2015","journal-title":"Brit Med J"},{"key":"R20-20250310","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jhep.2018.06.024","article-title":"EASL clinical practice guidelines on nutrition in chronic liver disease","volume":"70","author":"Merli","year":"2019","journal-title":"J Hepatol"},{"key":"R21-20250310","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/liv.14175","article-title":"Adipopenia correlates with higher portal pressure in patients with cirrhosis","volume":"39","author":"Rodrigues","year":"2019","journal-title":"Liver Int"},{"key":"R22-20250310","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1111\/liv.14217","article-title":"The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis","volume":"39","author":"Paternostro","year":"2019","journal-title":"Liver Int"},{"key":"R23-20250310","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.14309\/ajg.0000000000000959","article-title":"Sarcopenia does not worsen survival in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt for refractory ascites","volume":"115","author":"Benmassaoud","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"R24-20250310","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cgh.2016.10.028","article-title":"Sarcopenia is risk factor for development of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement","volume":"15","author":"Nardelli","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R25-20250310","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2017.05.006","article-title":"Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding","volume":"67","author":"Wang","year":"2017","journal-title":"J Hepatol"},{"key":"R26-20250310","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1007\/s10620-021-07099-8","article-title":"Visceral adipose tissue inflammation and radiographic visceral-to-subcutaneous adipose tissue ratio in patients with cirrhosis","volume":"67","author":"Ha","year":"2022","journal-title":"Digest Dis Sci"},{"key":"R27-20250310","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/hep.29410","article-title":"L-ornithine L-aspartate in bouts of overt hepatic encephalopathy","volume":"67","author":"Sidhu","year":"2018","journal-title":"Hepatology"},{"key":"R28-20250310","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/jhbp.770","article-title":"High-mobility group protein b1: a predictive biomarker for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt","volume":"27","author":"Chen","year":"2020","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R29-20250310","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s13539-012-0069-3","article-title":"Consilience in sarcopenia of cirrhosis","volume":"3","author":"Dasarathy","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R30-20250310","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/apt.15044","article-title":"Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis","volume":"49","author":"Rodrigues","year":"2019","journal-title":"Aliment Pharm Therap"},{"key":"R31-20250310","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3350\/cmh.2019.0015","article-title":"Sarcopenia: Ammonia metabolism and hepatic encephalopathy","volume":"25","author":"Jindal","year":"2019","journal-title":"Clin Mol Hepatol"},{"key":"R32-20250310","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.4254\/wjh.v7.i30.2940","article-title":"Nutritional assessment in cirrhotic patients with hepatic encephalopathy","volume":"7","author":"Romeiro","year":"2015","journal-title":"World J Hepatol"},{"key":"R33-20250310","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.dld.2019.09.004","article-title":"The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease","volume":"51","author":"Lattanzi","year":"2019","journal-title":"Dig Liver Dis"},{"key":"R34-20250310","doi-asserted-by":"crossref","first-page":"7863","DOI":"10.1096\/fj.201802457RR","article-title":"Reduced mitochondrial lipid oxidation leads to fat accumulation in myosteatosis","volume":"33","author":"Gumucio","year":"2019","journal-title":"Faseb J"},{"key":"R35-20250310","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.jceh.2014.06.004","article-title":"Pathogenesis of hepatic encephalopathy: Role of ammonia and systemic inflammation","volume":"5","author":"Aldridge","year":"2015","journal-title":"J Clin Exp Hepatol"},{"key":"R36-20250310","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fphys.2017.00087","article-title":"The need for standardized assessment of muscle quality in skeletal muscle function deficit and other aging-related muscle dysfunctions: A symposium report","volume":"8","author":"Correa-de-Araujo","year":"2017","journal-title":"Front Physiol"},{"key":"R37-20250310","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3390\/jpm13040682","article-title":"Overweight\/obesity increases the risk of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients","volume":"13","author":"Lihong","year":"2023","journal-title":"J Pers Med"},{"key":"R38-20250310","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/MEG.0000000000001452","article-title":"Diabetes mellitus increases the risk of hepatic encephalopathy after a transjugular intrahepatic portosystemic shunt in cirrhotic patients","volume":"31","author":"Yin","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R39-20250310","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1111\/liv.15060","article-title":"The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt","volume":"41","author":"Gioia","year":"2021","journal-title":"Liver int"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCG.0000000000002014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T17:08:47Z","timestamp":1741626527000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCG.0000000000002014"}},"subtitle":["A Multicentre Cohort Study"],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0000000000002014","relation":{},"ISSN":["1539-2031"],"issn-type":[{"value":"1539-2031","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,30]]},"assertion":[{"value":"2023-11-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}